tbuckley/cabot-search huggingface dataset:
Abstract A032: The role of ASIC2 and calcium influx in epithelial ovarian cancer pathogenesis
Authors: Tanvi Joshi, Annelise Wilhite, Sagar Chokshi, Mary Howard Singleton, Jennifer Scalici, Kevin Lee
Journal: Cancer Research (2024)

Abstract Objective: Inflammation associated with incessant ovulation plays a key role in epithelial ovarian cancer (EOC) pathogenesis. Ion channels, such as acid-sensing ion channel-2 or ASIC2 is known to be upregulated in inflammatory conditions and may play a role in calcium ion dysregulation. Here, we describe a potential relationship between ASIC2 and intracellular calcium levels in EOC development and progression. Methods: EOC cell lines OVCAR-8, ES-2 and SKOV-3 were grown to sub-confluence prior to experimentation. Global extracellular pH was changed with the use of hydrochloric acid (HCl) over various time points at hours (h): 2 h, 4 h, 8 h, 12 h and 24 h. ASIC2 expression was subsequently measured via western blot. Intracellular pH was measured with the use of pH-sensitive pHrodo red dye. Cytosolic pH was determined across all cell lines at baseline and after treatment with a known ASIC2 inhibitor: Diminazene (10 μM) over 30 minutes. Intracellular calcium levels were measured with a Fluo Calcium Indicator at baseline and with similar ASIC2 inhibition. Live cell imaging was utilized on a Nikon A1r confocal microscope. Results: Changing global, extracellular pH to 6.0 and 6.5 across various time points from 2-24 h did not affect ASIC2 protein expression via western blot analysis. We then utilized a pH-sensitive assay to determine whether intracellular pH changes were associated with ASIC2 expression. Interestingly, intracellular pH was noted to increase across most cell lines with ASIC2 inhibition via Diminazene treatment. There was a statistically significant increase in pH in ES2 and OVCAR8 cell lines. Because ASIC2 is known to result in influx of various ions, assessment of intracellular calcium levels was performed first after 30 minutes of Diminazene treatment. There was a corresponding significant increase in intracellular calcium levels in ES2 cells after ASIC2 inhibition. And there was a small trend, albeit not significant, toward a similar increase across SKOV-3 and OVCAR-8 cells. Conclusion: There seems to be a role for ASIC2 in EOC, particularly in the context of inflammation as noted by changes in intracellular pH levels. It is likely that ASIC2 may mediate changes in intracellular calcium signaling and promote tumorigenesis in ovarian cancer. Citation Format: Tanvi Joshi, Annelise Wilhite, Sagar Chokshi, Mary Howard Singleton, Jennifer Scalici, Kevin Lee. The role of ASIC2 and calcium influx in epithelial ovarian cancer pathogenesis [abstract]. In: Proceedings of the AACR Special Conference on Ovarian Cancer; 2023 Oct 5-7; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_2):Abstract nr A032.
Abstract A046: Exogenous CD200 suppressing T cells is CD200R1 independent
Authors: Zhengming Xiong, Micheal R. Olin
Journal: Cancer Research (2024)

Abstract As one of immune checkpoint blockade, CD200 is widely considered to exert immunosuppressive and inflammatory suppressive functions through receptors on its immune cell membrane (1,2,3). Unlike the widespread use of anti-PD-1, few successful studies have been reported in the use of anti-CD200/CD200R in anti-tumor immunotherapy researches. This makes it necessary to re-understand the mechanism of action and biological effects of CD200 protein. We studied antigen-presenting cells and T cells in an environment where CD200R1 knockout macrophages and wild-type macrophages interact with antigen-specific T cells, respectively, and in vitro in human PBMCs using synthetic CD200 membrane segments. Changes in immune function and gene expression in signaling pathways is also involved. The experimental results show that comparing with inactivated human PBMC, CD200-Fc fusion protein significantly inhibited the division of human PBMC cells activated by ConA (Fig 1). Further experiments showed that the recombinant CD200 extracellular domain has a positive inhibitory effect on IL6, TNF and IL17A produced from PBMCs activated by PMA + ionomycin but has no effect on the production of IFNr. The recombinant CD200 extracellular domain itself can induce a large amount of IL6. (Fig.2). In view of the close relationship between IFNr and antigen-TCR function, we speculate that CD200 protein has no direct relationship with immunosuppression of antigen-specific T cells. To this end, we performed the following experiments. When CD200 plus gp100 antigen polypeptide acted on only CD200R1 knock out macrophages, cocultured gp100 antigen-specific CD3 T cells produced significantly less IFNr and TNF than only gp100 antigen polypeptide stimulation (IFNr 227.8pg/ml vs 803.2 pg/ml, p &amp;lt;0.01); TNF 3984pg/ml vs 5187pg/ml, p &amp;lt;0.0001). Moreover, when using CD200 plus gp100 antigen polypeptide as stimuli of the APC, IFNr and TNF production during T cells cocultured with the APCs are not significant different between the macrophage groups with and without CD200R1 gene (IFNr 161.8pg/ml vs 227.8 pg/ml p&amp;gt; 0.05; TNF 3715pg/ml vs 3984pg/ml, p&amp;gt; 0.05). This indicates that CD200R1 is not required for the immunosuppressive function of CD200 in relation with antigen. Secondly, IFNr produced by T cells induced by gp100 on CD200R1 knockout macrophages was significantly higher than that of wild-type macrophages (IFNr 803.2pg/ml vs 329.3pg/ml, p&amp;lt;0.01), which indicates that inactivated CD200R1 itself has positively regulated the activity of the antigen-TCR system. (Fig.4) In short, exogenous CD200 induces immunosuppression of antigen-specific T cells through a CD200R1-independent mechanism. Citation Format: Zhengming Xiong, Micheal R. Olin. Exogenous CD200 suppressing T cells is CD200R1 independent [abstract]. In: Proceedings of the AACR Special Conference on Brain Cancer; 2023 Oct 19-22; Minneapolis, Minnesota. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_1):Abstract nr A046.
Abstract A021: The beta-arrestin1/endothelin axis bolsters a CAF-dependent invadosome activity and ovarian cancer metastatic potential
Authors: Danila Del Rio, Ilenia Masi, Flavia Ottavi, Erica Salvati, Valentina Caprara, Anna Bagnato, Sara Giannitelli, Francesca Spadaro, Laura Rosanò
Journal: Cancer Research (2024)

Abstract The recruitment of fibroblasts to tumors and their activation to cancer-associated fibroblasts (CAFs) is a strategy used by tumor cells to guide extracellular matrix (ECM) remodeling, invasion, and metastasis, highlighting the need to dissect molecular mechanisms involved in CAF function. Endothelin-1 (ET-1) regulates cancer/stroma crosstalk, supporting serous ovarian cancer (SOC) progression. By binding its receptors ETA and ETB, ET-1 allows the recruitment of β-arrestin1 (β-arr1) and the generation of signaling complexes regulating tumor progression. However, how ET-1 receptors might “educate” ovarian fibroblasts (HOFs) to supply altered ECM needs and bolster metastasis is to be investigated. This study identifies ET-1 as a critical factor in activating CAFs capable of proteolytic ECM remodeling by invadosome and creating heterotypic spheroids with cancer cells with favorable metastatic abilities. An autocrine/paracrine ET-1/ETA/BR/β-arr1 loop promotes HOF proliferation, an increased CAF marker expression, secretion of proinflammatory cytokines, collagen contraction ability, and motility. Moreover, ET-1 allows ECM remodeling by supporting the lytic activity of invadosome and activation of integrin beta1. Of note, ET-1 signaling favors the formation of heterotypic HOF/SOC spheroids with enhanced ability to survive, migrate through mesothelial monolayer mesothelial, and invade, representing metastatic units. Blockade of ETA/BR or β-arr1 silencing prevents CAF activation, invadosome function, mesothelial clearance, and invasive ability of heterotypic spheroids. In vivo, therapeutical inhibition of ETA/BR with bosentan markedly reduced the metastatic potential of HOF/SOC spheroids. Our findings support a model in which ET-1/β-arr1 amplifies tumor/stroma interaction via CAF activation and fuels HG-SOC metastatic properties, which might be hampered by ETA/BR antagonists. Citation Format: Danila Del Rio, Ilenia Masi, Flavia Ottavi, Erica Salvati, Valentina Caprara, Anna Bagnato, Sara Giannitelli, Francesca Spadaro, Laura Rosanò. The beta-arrestin1/endothelin axis bolsters a CAF-dependent invadosome activity and ovarian cancer metastatic potential [abstract]. In: Proceedings of the AACR Special Conference on Ovarian Cancer; 2023 Oct 5-7; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_2):Abstract nr A021.
Abstract IA016: Metabolic reprogramming and cancer progression in patients
Authors: Ralph J. DeBerardinis
Journal: Cancer Research (2024)

Abstract Many human diseases, including cancer, involve alterations of cellular metabolism caused either directly or indirectly by mutations in genes that regulate the metabolic network. In cancer, reprogrammed metabolic activities arising from mutations in tumor suppressors and oncogenes are thought to contribute both to cancer initiation and progression, particularly metastasis. Many factors intrinsic or extrinsic to the cancer cell impact metabolic properties within tumors and influence vulnerabilities that could presumably be exploited to suppress cancer progression. Although many insights about metabolic regulation have been derived from reductionist models of cancer cell growth in culture, these models do not incorporate all of the factors – particularly cancer cell-extrinsic factors – that contribute to cancer progression. I will describe approaches to assess cancer metabolism within intact tumors, including in cancer patients. We use a multidisciplinary approach to infuse 13C-labeled nutrients (13C-glucose, 13C-acetate, 13C-glutamine) during surgical tumor resection in patients with malignancies in the brain, lung, kidney and other organs. Isotope labeling in metabolites extracted from tumors and adjacent, nonmalignant tissue provides information metabolic pathways activated or repressed in the tumors. By following clinical outcomes over time, we have identified labeling features and pathways that correlate with metastasis and early demise. I will discuss how these features reflect the evolution of metabolic properties and liabilities during human cancer progression, and how parallel studies in mice have allowed us to define mechanisms by metabolism supports metastasis. Citation Format: Ralph J. DeBerardinis. Metabolic reprogramming and cancer progression in patients [abstract]. In: Proceedings of the AACR Special Conference on Brain Cancer; 2023 Oct 19-22; Minneapolis, Minnesota. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_1):Abstract nr IA016.
Radiomics analysis using non-contrast computed tomography for predicting HDU admission in patients with acute pyelonephritis
Authors: T. Horie, M. Fujiwara, A. Hasegawa, T. Kimura, K. Suzuki, H. Tanaka, T. Ito, R. Yasujima, R. Ikeda, S. Matsumoto, K. Yoshitomi, M. Kobayashi, Y. Nakamura, W. Chen, B. Fan, Y. Ishikawa, S. Fukuda, Y. Waseda, H. Tanaka, S. Yoshida, Y. Fujii
Journal: European Urology (2024)
Effect of HLA genotype on anti-PD-1 antibody treatment for advanced renal cell carcinoma
Authors: T. Tanegashima, M. Shiota, H. Miyake, M. Takahashi, M. Oya, N. Tsuchiya, N. Masumori, H. Matsuyama, W. Obara, N. Shinohara, K. Fujimoto, M. Nozawa, K. Ohba, C. Ohyama, K. Hashine, S. Akamatsu, T. Kamba, K. Mita, M. Gotoh, S. Tatarano, M. Fujisawa, Y. Tomita, S. Tokunaga, M. Eto
Journal: European Urology (2024)
Proportion of Gleason 8-10 prostate cancer found on biopsy and tumor aggressiveness in matched cohorts of men in Asia and Western countries
Authors: L. Dong, K. Lajkosz, R. Sanchez-Salas, R.V. Tiwari, Y. Zhu, C.P. Dias dos Santos, B. Dong, J. Pan, A. Chan, D. Woon, G. Kulkarni, N. Perlis, R. Hamilton, L. Klotz, C.J.D. Wallis, P. Macek, K.J. Tay, A. Toi, A. Finelli, N.E. Fleshner, X. Cathelineau, T.H. Van Der Kwast, W. Xue, A.R. Zlotta
Journal: European Urology (2024)
Tissue distribution of ceftazidime-avibactam in kidney tissue in healthy rats and pigs using a microdialysis technique
Authors: Maxime Vallée, Jérémy Moreau, Isabelle Lamarche, Céline Barc, Nathalie Kasal-Hoc, Hélène Mirfendereski, Vincent Aranzana-Climent, William Couet, France Cazenave-Roblot, Sandrine Marchand
Journal: European Urology (2024)
Renal biopsy does not affect mortality in renal mass patients when confronted with upfront surgery: A propensity score adjusted analysis
Authors: F. Belladelli, C. Re, F. Cei, G. Musso, G. Rosiello, D. Cignoli, C. Piccolo, L. Salerno, F. Iannace, D. Canibus, F. Fiorio, R. Matloob, R. Bertini, A. Salonia, F. De Cobelli, G. Brembilla, S. Gusmini, G. Guazzarotti, M. Gambirasio, A. Briganti, F. Montorsi, A. Larcher, U. Capitanio
Journal: European Urology (2024)
Posterior Urethral Valves (PUV) and Anterior Urethral Valves (AUV) with and without concomitant PUV: Matched cohort study at a high-risk pediatric center
Authors: J. Richter, J. Dos Santos, C. Sánchez, C. Moreno Bencardino, M.E. Chua, J.K. Kim, A. Khondker, A.J. Lorenzo, M. Rickard
Journal: European Urology (2024)
The quantification of GSP4 volume is superior to ISUP GG classification and %GSP4 for predicting adverse outcomes in radical prostatectomy patients
Authors: S.L.A. Scuderi, A. Tin, A. Stabile, E. Mazzone, L. Quarta, P. Zaurito, M. Ciabattini, A. Cosenza, M. Brancaccio, R. Leni, J. Klug, S. Porwal, N.P. Tenace, R. Lucianò, G. Gandaglia, J.A. Eastham, F. Montorsi, A. Briganti, A.J. Vickers
Journal: European Urology (2024)
The new 2019 Bosniak classification of complicated renal cysts. Radiopathological correlation and critical review
Authors: H. Alfambra Fernandez, C. Sebastià, T. Ajami, S. Jiménez, L. Rodríguez, R. López, C. Nicolau, A. Alcaraz, M. Musquera
Journal: European Urology (2024)
Comparison of qSOFA score and SIRS criteria for assessing the risk for severe acute kidney injury development and mortality in febrile urinary tract infection
Authors: N. Fujita, M. Momota, O. Soma, D. Noro, H. Ito, T. Yoneyama, Y. Hashimoto, K. Yoshikawa, C. Ohyama, S. Hatakeyama
Journal: European Urology (2024)
Combined endoscopic and robot-assisted repair of vescicovaginal fistula and bladder endometriosis: Role of peritoneal flap
Authors: G. Albo, F. Ciamarra, L. Jannello, V. Pagliarulo, A. Quistini, L. Boeri, S.P. Zanetti, E. De Lorenzis, R. De Mitri, E. Scanferla, F. Longo, M. Garcia, E. Montanari
Journal: European Urology (2024)
Impact of volume difference between 3D transrectal ultrasound and MRI segmentation on the outcome of fusion MRI-Targeted prostate biopsy
Authors: L. Lenfant, C. Beitone, J. Troccaz, M. Roupret, T. Seisen, R. Renard-Penna, S. Voros, P.C. Mozer
Journal: European Urology (2024)
Reduction of antibiotic use around prostatic biopsy in a prostate cancer network
Authors: C.H. Bangma, J. Rietbergen, S. Klaver, M. Busstra, E. Planken, R. Pelger, G. Andel van, P. Aussems, L. Venderbos, N. Borggreven, R. Raaymakers, B. Merks
Journal: European Urology (2024)
Chronic Kidney Disease (CKD) in children with Meningomyelocele (MMC): Risk factors and clinical outcomes
Authors: A. El Helaly, A. Alotay, A. Alfaddagh, A. Bashareef, M. Aljaafar, M. Alhagbani, M. alghanbar, Z. Nakshabandi, O. Sarhan
Journal: European Urology (2024)
Native nephrectomy and arterial embolization of native kidney in autosomal dominant polycystic kidney disease patients: Indications, timing and postoperative outcomes. A systematic review by the EAU-YAU Kidney Transplantation working group
Authors: T. Prudhomme, R. Boissier, V. Hevia, R. Campi, A. Pecoraro, A. Piana, B. Banuelos, M.I. Dönmez, F. Sallusto, A. Breda, A. Territo
Journal: European Urology (2024)
Association of area of deprivation index with prostate cancer incidence and lethality over a contemporary North American cohort
Authors: M. Finati, G.O. Cirulli, G. Chiarelli, A. Stephens, M. Davis, S. Tinsley, M. Butaney, S. Arora, C. Morrison, A. Sood, N. Buffi, G. Lughezzani, A. Salonia, A. Briganti, F. Montorsi, C. Bettocchi, G. Carrieri, C. Rogers, F. Abdollah
Journal: European Urology (2024)
Micro-ultrasound guided prostate biopsies: evaluation of PRI-MUS score in a high-volume experience
Authors: D. Maffei, P.P. Avolio, S. Moretto, A. Piccolini, M. Aljoulani, F. Dagnino, M. Paciotti, R.F. Hurle, F. De Carne, A.R. Saita, G.F. Guazzoni, N.M. Buffi, M. Lazzeri, G. Lughezzani
Journal: European Urology (2024)
Surveillance interruption and need for active treatment in Von Hippel-Lindau disease: implications for clinical management and trial design
Authors: F. Cei, C. Re, F. Belladelli, L. Salerno, A. Falini, S. Calloni, F. De Cobelli, G. Guazzarotti, P. Mortini, J.F. Capitanio, M. Bailo, F. Bandello, R. Lattanzio, M. Falconi, S. Partelli, F. Muffatti, L. Castellino, L.O. Piccioni, R.A. Battista, I. Rowe, F. Montorsi, U. Capitanio, A. Larcher, A. Salonia
Journal: European Urology (2024)
Prostate biopsy features and risk of biochemical recurrence after robot-assisted radical prostatectomy: High-volume tertiary care hospital experience
Authors: C. Collà Ruvolo, G. Sorce, N. Freco, M. Ticonosco, S. Rebuffo, A. Pissavini, M. Belmonte, G. De Naeyer, F. D Hondt, R. De Groote, A. Mottrie
Journal: European Urology (2024)
Assessing the influence of recurrent urinary tract infections on sexual function: A case-control study
Authors: J. Medina-Polo, A. Guntinas-Castillo, C. Calzas-Montalvo, M.A.D.P. Caro-González, A. Arrébola-Pajares, S. Juste-Álvarez, A. de la Calle-Moreno, J. Romero-Otero, A. Rodríguez-Antolín
Journal: European Urology (2024)
Low-absent expression of TROP-2 in sarcomatoid subtype of bladder cancer: Immunohistochemical evaluation of TROP-2 in a series of muscle invasive bladder cancer
Authors: A. Cimadamore, C. Franzese, G. Giannarini, B. Miani, M. Moschini, D. Cesselli, C. Di Loreto, A. Crestani
Journal: European Urology (2024)
Identifying infrequent genetic changes in monozygotic twins afflicted with hypospadias via targeted panel sequencing
Authors: D. Kim, Y. Kim, D. Kim, H. Kang, S. Kang, Y. Jung, J. Choe, D. Shin, J. Cho, J. Park, K. Nam, S.H. Song, K.S. Kim
Journal: European Urology (2024)
Diagnostic performance of multiparametric magnetic resonance imaging before renal biopsy using Clear Cell Likelihood Score (ccLS)
Authors: C. Re, G. Brembilla, R. Pennella, T. Russo, M. Cosenza, F. Cei, F. Belladelli, D. Cignoli, G. Musso, G. Basile, G. Rosiello, D. Canibus, F. Fiorio, R. Bertini, P. Verze, A. Salonia, A. Briganti, F. Montorsi, A. Larcher, F. De Cobelli, U. Capitanio
Journal: European Urology (2024)
Predicting positive surgical margins in patients treated with robot-assisted partial nephrectomy: Results from a prospectively maintained dataset of a single tertiary referral center
Authors: V. Salamone, A. Cadenar, A. Sandulli, A.A. Grosso, L. Lambertini, E. Massaro, L. Gajo, S. Coco, M. Bacchiani, S. Giudici, F. Di Maida, R. Fantechi, G. Vittori, A. Minervini, A. Mari
Journal: European Urology (2024)
Long-term analysis of treatment decision regret: Importance of the decision-making process and postoperative HRQOL after treatment for early-stage prostate cancer
Authors: T. Osawa, M. Sato, K. Nishioka, T. Miyazaki, S. Takahashi, T. Mori, T. Hashimoto, H. Miyata, R. Matsumoto, T. Abe, K. Ohashi, S. Murai, Y.M. Ito, N. Shinohara
Journal: European Urology (2024)
Targeting glutamine addiction to induce ferroptosis with potent drug combination therapy for renal cell carcinoma
Authors: A. Takeuchi, M. Sumitomo, A. Yoshimura, T. Watanabe, H. Yanagi, E. Sugihara, K. Zennami, K. Takahara, H. Saya, R. Shiroki
Journal: European Urology (2024)
Perioperative outcomes and evolution of penile prosthesis implantation in Germany: Results from the GRAND study
Authors: N. Pyrgidis, G.B. Schulz, M. Chaloupka, Y. Volz, P. Pfitzinger, S. Rodler, E. Berg, P. Weinhold, F. Jokisch, C. Stief, A. Becker, J. Marcon
Journal: European Urology (2024)
Male genital image and quality of life after penile prosthesis implantation: A patient perspective
Authors: N. García Formoso, A. Meza Huamán, N. Herrera Aranda, P. Calleja Hermosa, R. Varea Malo, P. Giral Villalta, F. Cáceres Rodríguez, O. Gorría Cardesa, F. Campos Juanatey
Journal: European Urology (2024)
Deceased donor robotic-assisted kidney transplantation: The ERUS–RAKT experience
Authors: M. Musquera, T. Prudhomme, L. Peri, A. Pecoraro, A. Territo, B. Etcheverry, M. Ortved, A. Roder, I. Mirza, G. Vignolini, M. Rohrsted, N. Doumerc, F. Vigues, A. Breda, A. Alcaraz, S. Serni, R. Campi
Journal: European Urology (2024)
Severity of penile curvature in patients with Peyronie’s disease and erectile dysfunction does not correlate with dynamic colour Doppler duplex ultrasound parameters: Findings from a real-life cross-sectional study
Authors: E. Pozzi, F. Belladelli, C. Corsini, A. Bertini, M. Raffo, F. Negri, F. Cattafi, M. Oddo, M. Malvestiti, R. Ramadani, L. Candela, P. Capogrosso, L. Boeri, L. Zahiti, A. Mattei, A. d’Arma, F. Montorsi, A. Salonia
Journal: European Urology (2024)
Radical cystectomy in patients over 80 years of age: Comparison of age and common preoperative geriatric assessment scores in predicting 30-days postoperative morbidity in a monocentric cohort of 429 patients
Authors: G. Duwe, I. Wagner, K.E. Banasiewicz, L.J. Frey, N.D. Fischer, N. Rölz, M. Haack, R. Mager, P. Sparwasser, I. Tsaur, M.M. Kamal, A. Haferkamp, M.P. Brandt, T. Höfner
Journal: European Urology (2024)
Outcomes for RIRS in the setting of multiple and large renal stones (&gt;15mm) in children: Findings from a multicenter and real-world setting
Authors: P. Juliebø-Jones, B.K. Somani, V. Gauhar, O. Traxer, K.Y. Fong, D. Castellani, Y.Q. Madarriaga, A. Bujons Tur
Journal: European Urology (2024)
Comparing the diagnostic accuracy of mpMRI and MicroUS for detecting clinically significant prostate cancer in patients with previous negative prostate biopsy
Authors: N. Frego, V. Fasulo, D. Maffei, P. Arena, P.P. Avolio, G. Chiarelli, E. Beatrici, F. Sordelli, F. De Carne, G. Garofano, F. Dagnino, M. Aljoulani, M. Paciotti, A.R. Saita, M. Lazzeri, R. Hurle, N.M. Buffi, P. Casale, G. Lughezzani
Journal: European Urology (2024)
Preoperative or intraoperative renal biopsy increases the accuracy in predicting lymph node invasion in patients with renal cell carcinoma
Authors: F. Belladelli, C. Re, F. Cei, G. Musso, G. Rosiello, D. Cignoli, D. Canibus, F. Fiorio, R. Bertini, A. Salonia, F. De Cobelli, G. Brembilla, M. Roupret, A. Esposito, A. Palmisano, C. Piccolo, M. Gambirasio, R. Lucianò, N. Tenace, A. Briganti, F. Montorsi, A. Larcher, U. Capitanio
Journal: European Urology (2024)
Correlation between early recovery of urinary continence and length of spared urethra after robotic assisted radical prostatectomy: A prospective multicenter study
Authors: F.M. Valenzi, A. Fuschi, Y. Al Salhi, P.P. Suraci, S. Scalzo, A. Antonioni, O.A. Rera, M.B. Sequi, D. Graziani, F. Gianfrancesco, G. Martino, G. Candita, A. Sciarra, M. Moriconi, C. De Nunzio, G. Tema, A. Zucchi, M. Pacini, A. Carbone, A.L. Pastore
Journal: European Urology (2024)
Multicenter evaluation of Multi-Incision Technique (MIT) with malleable prosthesis in Peyronie’s disease: A lengthening strategy in patients with or without erectile dysfunction
Authors: G. Maiolino, A. Fraile Poblador, E. Fernández-Pascual, M. Hevia Palacios, J.I. Martínez-Salamanca
Journal: European Urology (2024)
Transperineal approach is safer than transrectal approach in MRI-ultrasound fusion prostate biopsy: An analysis using propensity score matching
Authors: H. Tanaka, M. Kobayashi, K. Yoshitomi, B. Fan, M. Fujiwara, Y. Nakamura, Y. Ishikawa, S. Fukuda, Y. Waseda, H. Tanaka, S. Yoshida, Y. Fujii
Journal: European Urology (2024)
Perioperative surgical complications in robot-assisted vs. pure laparoscopic living donor nephrectomy: A European Robotic Urology Section (ERUS) RAKT working group study
Authors: R. Campi, A. Pecoraro, A. Gallioli, A. Territo, G. Basile, C. Berlin, B. Etcheverry, M. Musquera, J. Vangeneugden, M. Orteved, P. Zeuschner, A. Volpe, R. Garcia-Baquero, B. Kocak, M. Idu, P. Fornara, M. Rohrsted, A. Alcaraz, N. Doumerc, F. Vigues, K. Decaestecker, S. Serni, A. Breda
Journal: European Urology (2024)